2020 annual financial data
China SXT Pharmaceuticals 2020 Operating margin
Direct answer
Operating margin was -25.98%.
Operating income was -1,341,117 USD and net income was -10,287,872 USD.
Operating cash flow was 934,247 USD.
Get free China SXT Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,162,268 USD
- Operating income
- -1,341,117 USD
- Net income
- -10,287,872 USD
- Operating cash flow
- 934,247 USD